BIONET Therapeutics Corp. (TPEX:7808)
Taiwan · Delayed Price · Currency is TWD 28.70
-1.25 (-4.17%)
At close: Jul 29, 2026
BIONET Therapeutics Market Cap
BIONET Therapeutics has a market cap or net worth of 2.16 billion as of July 29, 2026. Its market cap has decreased by -39.73% in one year.
Market Cap
2.16B
Enterprise Value
1.11B
Revenue
154.48M
Ranking
n/a
PE Ratio
n/a
Stock Price
28.70
ChartMarket Cap Chart
Since December 12, 2024, BIONET Therapeutics's market cap has decreased from 3.82B to 2.16B, a decrease of -43.49%. That is a compound annual growth rate of -29.58%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 29, 2026 | 2.01B | -48.93% |
| Dec 31, 2025 | 3.93B | 20.99% |
| Dec 31, 2024 | 3.25B | -14.77% |
| Dec 12, 2024 | 3.82B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| TLC BioSciences | 28.52B |
| HanchorBio | 18.23B |
| Elixiron Immunotherapeutics (Cayman) Limited | 10.98B |
| Intelligene | 7.08B |
| Uwell Biopharma | 6.63B |
| Tripartite Therapeutics | 5.81B |
| Obigen Pharma | 3.85B |
| Pet Pharm Biotech | 2.90B |